Because of the clinics discharge policy, at the end of my appointment I was required to be given intramuscular self-injection training by my doctors nurse
The escalation arms landed at 19.9% (6/9 mg) and 16.4% (3/6/9 mg), and the 3 mg and 6 mg fixed arms came in at 12.4% and 17.6%
The risk-benefit calculation remains unclear
Preclinical studies lasting up to 6 weeks showed no adverse effects across liver, spleen, lung, kidney, brain, thymus, prostate, and ovary tissues
Educational, Transparent Care Transparency and education are foundational to uDrip IVs patient care philosophy
While these treatment approaches, both behavioral and pharmacological, hold promise for alleviating METH-induced neurological damage, their long-term efficacy, potential side effects, and real-world feasibility remain significant concerns